Nachrichten zur Bristol-Myers Squibb Co. Aktie

Bristol Myers says Opdivo performs well in kidney, lung cancer trials

Bristol Myers Squibb Co said on Monday that its blockbuster cancer immunotherapy Opdivo performed well in two separate late-stage trials, prolonging survival in…

Better Buy: GlaxoSmithKline vs. Bristol Myers Squibb

Two big drugmakers. One clear winner for investors....…

Top Research Reports for Comcast, Bristol-Myers & Walgreens

Top Research Reports for Comcast, Bristol-Myers & Walgreens...…

Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Intensity Therapeutics signs clinical collaboration agreement with Bristol Myers Squibb for advanced solid tumors

The program will evaluate the safety and efficacy of Intensitys lead product INT230-6, an investigational, novel and potent anti-cancer drug…

Should You Scoop Up Bristol Myers Squibb Shares-

Few stocks have avoided the mass coronavirus sell-offs, and Bristol Myers is no exception. Is this cheap stock worth a…

Bristol-Myers Squibb (BMY) Gains But Lags Market: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $60.02, marking a +1.87% move from the previous day....…

Bristol-Myers win in U.S. patent case against Gilead boosted to $1.2 bln

A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent…

Bristol-Myers Squibb persuaded a judge to boost damages to $1.2 billion in its patent-infringement case against Gilead

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers (BMY) Upgraded to Buy: Heres Why

Bristol-Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the companys earnings prospects. This…

Bristol Myers Applications for Opdivo-Yervoy Combo Accepted

Bristol Myers (BMY) applications for Opdivo in combination with Yervoy administered concomitantly with a limited course of chemotherapy have been…

Bristol Myers teams up with NeoImmuneTech to evaluate Nivolumab + NT-17

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19

Todays Daily Dose brings you news about Bristol Myers regulatory catalyst; Liquidias pulmonary arterial hypertension drug candidate; Moleculin Biotech joining…

Bristol-Myers Squibb applications for new use of O+Y accepted in U.S. and Europe

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $56.80, moving -1.85% from the previous trading session....…

Bristol-Myers Squibb to provide medicines to the unemployed & uninsured

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers/Accelerons Reblozyl Label Expansion Gets FDA Nod

Bristol Myers (BMY) and Acceleron received FDA nod for the label expansion of Reblozyl for MDS patients who require RBC…

Former Celgene Drug Earns a Key Approval for Bristol Myers Squibb

Reblozyl recently became the first treatment for adults with lower-risk myelodysplastic syndromes....…

Bristol-Myers Squibb: A Great Buy After The Pullback

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol Myers Squibb, Acceleron get FDA nod for Reblozyl to treat anaemia with lower-risk MDS

Myelodysplastic syndromes are a group of closely related blood cancers characterised by ineffective production of healthy red blood cells, white…

FDAs OKs new use of Acceleron and Bristol-Myers Squibbs luspatercept

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about trading options or stock in Bristol-Myers Squibb, Chevron Corp, Docusign, Intel Corp, or Tesla-

NEW YORK , April 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BMY,…

Morgan Stanley likes Bristol-Myers Squibb in premarket analyst action

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

DIVIDEND/INTEREST INFORMATION - 02.04.2020 - 2

FOLGENDE WERTPAPIERE WERDEN AM 02.04.2020 EX DIVIDENDE/ZINSEN GEHANDELT. THE EX-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL BE 02.04.2020. INSTR EXCH…

Bristol-Myers Squibb (BMY) Stock Moves -1.58%: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $54.86, moving -1.58% from the previous trading session....…

Bristol Myers, bluebird Submit BLA for Myeloma Drug to FDA

Bristol Myers (BMY) and bluebird file a biologics license application to the FDA seeking approval of idecabtagene vicleucel for heavily…

IONpath und Bristol Myers Squibb verfassen gemeinsamen Artikel zur Komplexität von Tumor-Mikroumgebungen für die Fachzeitschrift Laboratory Investigation

IONpath, Inc.: Menlo Park, Kalifornien (ots/PRNewswire) - IONpath, Inc. gab heute bekannt, dass gemeinsam mit Bristol Myers Squibb ein Artikel…

Bristol Myers Squibb and bluebird bio submit BLA for Idecabtagene Vicleucel to FDA

The submission is based on results from the pivotal Phase 2 KarMMa study. The KarMMa study evaluated the efficacy and…

DIVIDEND/INTEREST INFORMATION - 02.04.2020 - 1

FOLGENDE WERTPAPIERE WERDEN AM 01.04.2020 CUM DIVIDENDE/ZINSEN UND AM 02.04.2020 EX DIVIDENDE/ZINSEN GEHANDELT. THE PRE-DIVIDEND/INTEREST DAY OF THE FOLLOWING SHARES WILL…

Are You Looking for a High-Growth Dividend Stock- Bristol-Myers Squibb (BMY) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Bristol-Myers Ozanimod Approval, And Other News: The Good, Bad And Ugly Of Biopharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Bristol Myers Squibb Stock a Buy-

The pharma giant has been tossed into the discount bin, but thats not the only reason to consider buying its…

Whats Behind 300% Jump In Bristol-Myers Squibbs Cardiovascular Drugs Sales In The Last 4 Years-

Bristol-Myers Squibbs (NYSE: BMY) cardiovascular drug sales have surged 326% from $1.9 billion in 2015 to $7.9 billion in 2019,…

FDA approves Bristol Myers Squibbs ZEPOSIA oral treatment for relapsing forms of multiple sclerosis

ZEPOSIA, an oral medication taken once daily, is the only approved sphingosine-1-phosphate (S1P) receptor modulator that offers RMS patients an…

Novartis, life sciences firms collaborate with BMGF to fight against COVID-19 disease

Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, Gilead, GSK, Johnson & Johnson, Merck, Pfizer, Sanofi, BD and bioMérieux are…

U.S. Now Has Most Virus Cases, BSGM To Develop COVID-19 Drug, FDA Nod For BMY

Todays Daily Dose brings you news about BioSig Technologies foray into COVID-19 drug development, FDA approval of Bristol-Myers multiple sclerosis…

Why Bristol-Myers Squibbs Stock is Trading Higher Today

Bristol-Myers Squibb Company (NYSE: BMY) shares are trading higher after the company announced the FDA has approved ZEPOSIA, its new…

Zacks.com featured highlights include: Bristol-Myers Squibb, AmerisourceBergen, Leidos, Xcel Energy and Caseys General Stores

Zacks.com featured highlights include: Bristol-Myers Squibb, AmerisourceBergen, Leidos, Xcel Energy and Caseys General Stores...…

Bristol Myers Squibbs Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval

But the big drugmaker will delay its commercial launch due to the COVID-19 pandemic....…

UPDATE 3-U.S. FDA approves Bristol-Myers MS drug, launch delayed due to coronavirus

Bristol-Myers Squibb Co said on Thursday the U.S. Food and Drug Administration approved its multiple sclerosis (MS) treatment, Zeposia, but the launch…

The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizers Upjohn-Mylan Merger

Heres a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit…

UPDATE 2-U.S. FDA approves Bristol-Myers MS drug, launch delayed due to coronavirus

The U.S. Food and Drug Administration on Thursday approved Bristol-Myers Squibb Cos multiple sclerosis (MS) treatment, Zeposia, but its launch will be delayed…

Bristol-Myers Squibbs new MS drug is approved, launch delayed due to COVID-19

Shares of Bristol-Myers Squibb Co. gained 1% in premarket trading on Thursday after the drugmaker said the Food and…

UPDATE 1-U.S. FDA approves Bristol-Myers MS drug, coronavirus to delay launch

The U.S. Food and Drug Administration on Thursday approved Bristol-Myers Squibb Cos multiple sclerosis (MS) treatment, Zeposia, but its launch will be delayed…

U.S. FDA approves Bristol-Myers multiple sclerosis drug

The U.S. Food and Drug Administration on Thursday approved Bristol-Myers Squibb Cos multiple sclerosis (MS) treatment, Zeposia, one of the key treatments behind…

40% Upside For Bristol-Myers Squibb-

Bristol-Myers Squibb (NYSE: BMY) could see a 40% upside from the current levels, per our price estimate of $68, which…

Agios Provides Update on 2016 Collaboration Agreement with Celgene, a Wholly Owned Subsidiary of Bristol Myers Squibb

- Celgene Declines to Exercise Opt-in Right for MAT2A Inhibitor AG-270 -...…

China suspends Bristol-Myers cancer drug sales over findings at U.S. plant

Sales of Bristol-Myers Squibb Cos cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing…

REFILE-UPDATE 2-China suspends Bristol-Myers cancer drug sales over findings at U.S. plant

Sales of Bristol-Myers Squibb Cos cancer drug Abraxane have been suspended in China based on findings at a third-party manufacturing plant in…

UPDATE 1-China suspends Bristol-Myers cancer drug over findings at U.S. plant

China has suspended sale, import and use of Bristol-Myers Squibb Cos cancer drug, Abraxane, the U.S. drugmakers China marketing partner said on…